0001209191-22-057746.txt : 20221117 0001209191-22-057746.hdr.sgml : 20221117 20221117204011 ACCESSION NUMBER: 0001209191-22-057746 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221116 FILED AS OF DATE: 20221117 DATE AS OF CHANGE: 20221117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARER SOL J CENTRAL INDEX KEY: 0001247015 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40045 FILM NUMBER: 221400306 MAIL ADDRESS: STREET 1: C/O INSPIREMD, INC. STREET 2: 321 COLUMBUS AVENUE CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NexImmune, Inc. CENTRAL INDEX KEY: 0001538210 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-825-9810 MAIL ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-16 0 0001538210 NexImmune, Inc. NEXI 0001247015 BARER SOL J C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877 1 0 0 0 Common Stock 2022-11-17 4 P 0 75000 0.4789 A 1817814 D Common Stock 2022-11-16 4 P 0 125000 0.4824 A 1742814 D Common Stock 1538013 I Held by B&S NexImmune Holdco LLC Common Stock 346577 I Held by Joshua Barer The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4754 to $0.4890, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price Excludes 175,012 shares of common stock underlying options that are currently exercisable. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4557 to $0.4900, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price Mr. Sol Barer is the father of Joshua Barer, who is the sole manager of B&S NexImmune Holdco LLC and has sole voting and dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer is also a member of Barer & Son Capital, LLC, which is a member of B&S NexImmune Holdco LLC, but he does not have voting or dispositive control over the shares held by B&S NexImmune Holdco LLC. Mr. Sol Barer disclaims beneficial ownership of the securities held by B&S NexImmune Holdco LLC except to the extent of his pecuniary interest therein. Mr. Sol Barer is the father of Joshua Barer. Mr. Sol Barer disclaims beneficial ownership of the securities held by Joshua Barer except to the extent of his pecuniary interest therein. /s/ John Rudy, Attorney-in-fact 2022-11-17